It's all in the name: Does nomenclature for indolent prostate cancer impact management and anxiety?
Matthew T HudnallAnuj S DesaiKyle P TsaiAdam B WeinerAmanda X VoOliver S KoStephen JanEdward M SchaefferShilajit D KunduPublished in: Cancer (2021)
Within a hypothetical clinical scenario, nomenclature for low-grade prostate cancer affects initial perception of the disease and may alter subsequent decision making, including preference for active surveillance. Disease-specific education reduces the differential impact of nomenclature use, reaffirming the importance of comprehensive counseling and clear communication between the clinician and patient.